This drug is indicated in the treatment of breast cancer in post-menopausal women. We have earned worldwide reputation as one of the leading organizations engaged in offering Quinapyramine Sulphate. It is used both in adjuvant therapy such as following surgery and in metastatic breast cancer. It decreases the amount of estrogens that the body makes. Quinapyramine Sulphate belongs in the class of drugs known as aromatase inhibitors. It inhibits the enzyme aromatase, which is responsible for converting androgens, produced by women in the adrenal glands to estrogens.